Determination of functional portal-systemic shunting in patients submitted to hepatic angiography

Liver

Volumn 16, Issue 6, 1996, Pages 347-352

  Molino, G ^a   Battista, S ^a   Bar, F ^a   Garello, E ^a   Avagnina, P ^b   Grosso, M ^b   Spalluto, F ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

D sorbitol; Hepatic angiography; Liver cirrhosis; Portal systemic shunting

Indexed keywords

SORBITOL;

ADULT; AGED; ANTECUBITAL VEIN; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLLATERAL CIRCULATION; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER ANGIOGRAPHY; LIVER BIOPSY; LIVER CELL; LIVER CIRCULATION; LIVER CIRRHOSIS; MALE; PORTOSYSTEMIC ANASTOMOSIS; SUPERIOR MESENTERIC ARTERY;

EID: 0030466788     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00760.x     Document Type: Article

References (21)

1. BRADLEY. The hepatic circulation. In: American Physiologic Society, ed. Handbook of Physiology - Circulation, 3rd edn. Washington DC: American Physiologic Society, 1962: 1383-1438.
2. GEORGE CF. Drug kinetics and hepatic blood flow. Clin Pharmacokin 1979: 4: 433-448.
3. PORCHET H. BIRCHER J. Non-invasive assessment of portal-systemic bioavailability of oral-glyceryl trinitrate by digital plethysmography. Gastroenterology 1982: 82: 629-637.
4. NEAL AK, MEFFIN PJ, GREGORY PB, et al. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis. Gastroenterology 1979:77: 96-102.
5. TSCHANZ C, STEINER JA, HIGNTTE CE, HUFFMAN DH, AZARNOFF DL. Systemic availability of lidocaine in patients with liver disease. Clin Res 1977: 25: 609A.
6. BRANCH RA, SHAND DG. Propranolol disposition in chronic liver disease: a physiological approach. Clin Pharmacokin 1976: 1: 264-279.
7. KORNHAUSER DM, WOOD AJJ, VESTAL RE, WILKINSON GR, BRANCH RA, SHAND DG. Biological determinants of propranolol disposition in man. Clin Pharmacol Ther 1978: 23: 165-174
8. WOOD AJJ, KORNHAUSER DM, WILKINSON GR, SHAND DG, BRANCH RA. The influence of cirrhosis on steady-state blood concentration of unbound propranolol after oral administration. Clin Pharmacokin 1978: 3: 478-487.
9. POUPON RY, POUPON RE, LEBREC D, QUERNEC LL. DARIS F. Mechanism for reduced hepatic clearance and elevated plasma level of bile acids in cirrhosis. A study in patients with an end-to-side porto-caval shunt. Gastroenterology 1981: 80: 1438-1444.
10. CAVANNA A, MOLINO G, BALLARÉ M, et al. Non-invasive evaluation of portal-systemic shunting in man by D-sorbitol bioavailability. J Hepatol 1987: 5: 154-161.
11. MOLINO G, CAVANNA A, AVAGNINA P, BALLARE M, TORCHIO M. Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow. Dig Dis Sci 1987: 32: 753-58
12. MOLINO G, AVAGNINA P, BALLARÉ M, et al. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig Dis Sci 1991: 36: 1189-1196.
13. ZEEH J, LANGE H, BOSCH J, et al. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 1988: 95: 749-759.
14. HYAMS JS. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints. Gastroenterology 1983: 84: 30-33.
15. CAPOBIANCO P, SATEGNA GUIDETTI C. Hydrogen breath test as a diagnostic method for sorbitol absorption in healthy adults. IRCS Med Sci 1986: 14: 233.
16. CHILD III CG, TURCOTTE JG. Surgery and portal hypertension. In Child CG, ed. The liver and portal hypertension. Philadelphia: Saunders. 1964: 1-85.
17. BERGMEYER HU, GRUBER W, GUTTMAN I. D-sorbitol. In: Bergmeyer HU, ed. Methods of enzymatic analysis. New York and London: Verlag Chemie Weinheim and Academic Press. 1975: 1323-1330.
18. GUGLER R, LAIN P, AZARNOFF DL. Effect of porto-caval shunt on the disposition of drugs with and without first-pass effect. J Pharmacol Exp Ther 1975: 195: 416-423.
19. FEELY J, WILKINSON JR, WOOD AJJ. Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med 1980: 12: 692-695.
20. MOLINO G, AVAGNINA P, GARRONE C, SANSOÉ G, MAUTHE DEGERFELD M, BIANCO S. Time dependent modifications in end-to-side porto-caval shunt. J Hepatol 1992: 16: S103.
21. GILMORE IT, THOMPSON RPH. Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease. Gut 1980: 21: 123-127.